Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
glycoprotein\; involved in neuronal cell-to-cell interaction [RGD, Feb 2006].. Additionally we are shipping CD200 Antibodies (323) and CD200 Kits (38) and many more products for this protein.
Showing 10 out of 32 products:
our murine studies suggest that the coinhibi (show ARCN1 Proteins)tory molecule CD200 does not appear to play a prominent role in the early onset of CO (show CD200R1 Proteins)PD-like features
CD200 expression by tumor or host cells is important to regulation of immunotherapy in a mouse breast cancer model.
Following spinal cord injury, newly formed endothelial cells express CD200 ligand at time points critical for repair.
The CD200:CD200R (show CD200R1 Proteins) axis plays an immunoregulatory role in control of DSS (show PMP22 Proteins) induced colitis in mice
Data show that neutrophil infiltration of tissues was markedly decreased in CD200 antigen (tg) transgenic animals and increased in CD200 receptor 1 CD200R1 (show CD200R1 Proteins)(-/-) knockout mice.
we show a causal role for the CD200-CD200R (show CD200R1 Proteins) inhibitory axis in arteriogenesis in a murine hindlimb ischemia model.
CD200 upregulation in reactive glial cells is modulated through PPAR-gamma (show PPARG Proteins).
Anti-CD200R2 (show CD200R1L Proteins), anti-IL-9 (show IL9 Proteins), anti-IL-35, or anti-TGF-beta (show TGFB1 Proteins) abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice, and suggest combined role of mast cells and Tregs.
a role for both graft and host CD200/CD200R (show CD200R1 Proteins) expression in increased allograft survival.
The main sites of CD200/CD200 receptor (CD200R (show CD200R1 Proteins)) interaction in neonates and blood vessels, until adulthood, highlight the possible role of the CD200/CD200R (show CD200R1 Proteins) system in microglial development and renewal.
Residual CD200 activity may prevent completion of abortions via induction of Treg cells. In chronic histiocytic intervillositis, infiltrating maternal effector T cells may block Treg induction. An autocrine role for CD200-CD200R (show CD200R1 Proteins) interaction versus inhibition of soluble CD200 by soluble CD200R (show CD200R1 Proteins) is discussed.
patients with Autosomal dominant polycystic kidney disease have activated soluble CD200 levels which were related to renal function and inflammation.
correlation of sCD200 serum levels with COPD (show ARCN1 Proteins)-related parameters in humans with established disease revealed that the CD200/CD200R (show CD200R1 Proteins) axis may be mechanistically linked to the disease course in COPD (show ARCN1 Proteins) patients.
High expression of CD200 is associated with chronic lymphocytic leukemia.
Increased CD11b (show ITGAM Proteins)+ and CD200+ monocytes in those with a strong presence of BVN indicate that BVN development may be associated with retinal injury and a VEGF (show VEGFA Proteins)-mediated process that is either reflected or propelled by systemic changes in monocytes.
CD200 expression therefore may be used to help identify pulmonary small cell carcinoma in flow cytometry specimens.
Our data suggest a negative impact of CD200 expression in cytogenetically-normal acute myeloid leukemia (show BCL11A Proteins)
CD200 was expressed in 87% of the neuroendocrine neoplasms studied. CD200 is a relatively sensitive marker of neuroendocrine neoplasms and represents a potential therapeutic target in these difficult-to-treat malignancies.
Up-regulation of CD200 in MDS (show PAFAH1B1 Proteins) predicts poor prognosis.
this study shows that that CD200 suppresses the immune system's response to vaccines, and that blocking CD200 could improve the efficacy of cancer immunotherapy
glycoprotein\; involved in neuronal cell-to-cell interaction
, MRC OX-2 antigen
, OX-2 membrane glycoprotein
, antigen identified by monoclonal antibody MRC OX-2
, CD200 molecule
, Cd200 antigen
, cell surface protein (thymocyte antigen identified by monoclonal antibody MRC-OX2)